Ionis Pharmaceuticals


Pfizer Initiates Phase 2b Study For Cardiovascular Treatment

Pfizer (PFE) has kicked off a Phase 2b study of vupanorsen (ANGPTL3) in statin-treated patients with elevated non-high-density lipoprotein cholesterol and triglycerides (TGs). …

Barclays Boosts Price Target on Ionis Pharmaceuticals Inc (IONS) Following Positive Nusinersen Phase 3 Results

Barclays analyst Jonathan Eckard is cautiously optimistic now that Ionis Pharmaceuticals (NASDAQ:IONS) has tested its pipeline drug nusinersen, a short stretch of nucleic …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts